Global Viral Vector Manufacturing Market Share

Market Share of Global Viral Vector Manufacturing Industry

The viral vector manufacturing market is moderately competitive and has several key players. Owing to the growing demand for novel therapeutics to deal with life-threatening diseases, such as cancer, various smaller companies are also entering the market and holding a significant market share. Some of the key market players are Cognate BioServices Inc. (Cobra Biologics), Finvector, Fujifilm Holdings, Corporation (Fujifilm Diosynth Biotechnologies), Kaneka Corporation (Eurogentec), Merck KGaA, Uniqure NV, Oxford BioMedica PLC, Johnson & Johnson (Janssen Global Services LLC), AstraZeneca, Vibalogics, Danaher (Cytiva), Sanofi SA, F. Hoffmann-La Roche Ltd (Spark Therapeutics), Lonza, and Thermo Fisher Scientific Inc.

Viral Vector Manufacturing Market Leaders

1. FUJIFILM Diosynth Biotechnologies U.S.A. Inc.

2. Thermo Fisher Scientific

3. Cognate Bioservices

4. Merck KgaA

5. FinVector

*Disclaimer: Major Players sorted in no particular order